|
시장보고서
상품코드
2132269
의료 미들웨어 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 전개별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)Healthcare Middleware Market Size, Share & Trends Analysis Report By Type, By Deployment, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
의료 미들웨어 시장 요약
세계의 의료 미들웨어 시장 규모는 2025년에 37억 달러로 평가되며, 2026년 41억 달러에서 2033년까지 91억 달러로 성장할 것으로 예상되며, 2026년부터 2033년까지 CAGR은 12.0%에 달할 것으로 예측됩니다.
2025년에는 북미 시장이 매출 점유율의 30.7%를 차지하며 시장을 주도했습니다. 전자건강기록(EHR), 의료기기, 헬스케어 애플리케이션, 이종 데이터 시스템 간의 원활한 상호 운용성에 대한 수요가 증가함에 따라 의료 미들웨어 솔루션에 대한 수요가 확대되고 있습니다.
병원 및 의료 기관이 여러 EHR, 임상 애플리케이션, 의료기기, 데이터베이스, 레거시 시스템을 사용하는 등 의료 IT 환경의 세분화가 진행됨에 따라, 원활한 상호 운용성을 실현하는 미들웨어 솔루션에 대한 수요가 증가하고 있습니다. 의료 미들웨어는 이종 시스템 간의 데이터 교환 및 통신을 원활하게 하여, 기존 인프라를 교체하지 않고도 의료 제공자가 보다 유기적으로 연계된 IT 환경을 구축할 수 있도록 지원합니다. 따라서 표준화된 의료 데이터 교환과 상호 운용성이 점점 더 중요시됨에 따라 미들웨어 도입이 가속화되고 있습니다.
의료 서비스 제공자들은 EHR/EMR 시스템, 디지털 헬스 플랫폼, 클라우드 애플리케이션, 원격의료, 원격 환자 모니터링, 커넥티드 의료기기에 대한 투자를 점점 더 늘리고 있습니다. 디지털 시스템의 수가 증가함에 따라, 조직은 애플리케이션을 연결하고 데이터 흐름을 효율적으로 관리하기 위한 중간 기술 계층을 필요로 하고 있습니다. 미들웨어는 이러한 이종 기술 간의 통신 및 정보 교환을 가능하게 하며, 의료 분야의 지속적인 디지털화가 의료 미들웨어 산업의 중요한 성장 요인이 되고 있습니다.
의료 워크로드가 기존의 온프레미스 인프라에서 클라우드 및 하이브리드 환경으로 전환됨에 따라 통합의 복잡성이 증가하고 있습니다. 의료 기관은 클라우드 기반 애플리케이션을 온프레미스 EHR, 레거시 시스템, 의료기기, 데이터베이스와 연결해야 하는 경우가 빈번합니다. 미들웨어는 이러한 연결을 용이하게 하는 API, 통합 프레임워크, 메시징 기능, 데이터 변환 기능을 제공하여 클라우드 지원 및 하이브리드형 미들웨어 플랫폼에 대한 수요를 뒷받침하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 의료 미들웨어 시장 : 변수, 동향, 범위
제4장 의료 미들웨어 시장 : 유형별, 추정·동향 분석
제5장 의료 미들웨어 시장 : 전개별, 추정·동향 분석
제6장 의료 미들웨어 시장 : 용도별, 추정·동향 분석
제7장 의료 미들웨어 시장 : 최종 용도별, 추정·동향 분석
제8장 의료 미들웨어 시장 : 지역별, 추정·동향 분석
제9장 경쟁 구도
KSM 26.09.29Healthcare Middleware Market Summary
The global healthcare middleware market size was valued at USD 3.7 billion in 2025 and is projected to grow from USD 4.1 billion in 2026 to USD 9.1 billion by 2033, at a CAGR of 12.0% from 2026 to 2033. The market in North America dominated with a revenue share of 30.7% in 2025. The growing need for seamless interoperability among EHRs, medical devices, healthcare applications, and disparate data systems is driving demand for healthcare middleware solutions.
The increasing fragmentation of healthcare IT environments, with hospitals and healthcare organizations using multiple EHRs, clinical applications, medical devices, databases, and legacy systems, is driving demand for middleware solutions that enable seamless interoperability. Healthcare middleware facilitates data exchange and communication between heterogeneous systems, helping providers create a more connected IT environment without replacing existing infrastructure. The growing emphasis on standardized health data exchange and interoperability is therefore accelerating the adoption of middleware.
Healthcare providers are increasingly investing in EHR/EMR systems, digital health platforms, cloud applications, telehealth, remote patient monitoring, and connected medical devices. As the number of digital systems increases, organizations require an intermediary technology layer to connect applications and manage data flows efficiently. Middleware enables these disparate technologies to communicate and exchange information, making continued healthcare digitization a significant growth driver of the healthcare middleware industry.
The migration of healthcare workloads from traditional on-premises infrastructure toward cloud and hybrid environments is increasing integration complexity. Healthcare organizations frequently need to connect cloud-based applications with on-premises EHRs, legacy systems, medical devices, and databases. Middleware provides APIs, integration frameworks, messaging capabilities, and data transformation functions that facilitate these connections, supporting demand for cloud-enabled and hybrid middleware platforms.
Global Healthcare Middleware Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the healthcare middleware market report based on type, deployment, application, end use, and region:
- Type Outlook (Revenue, USD Billion, 2021 - 2033)
- Communication
- Platform
- Integration
- Others
- Deployment Outlook (Revenue, USD Billion, 2021 - 2033)
- Cloud
- On-premises
- Hybrid
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Clinical
- Financial
- Operational & Administrative
- Others
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Healthcare Providers
- Healthcare Payers
- Pharmaceutical & Life Sciences Companies
- Medical Device Companies
- Clinical Laboratories
- Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Brazil
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Methodology segmentation & scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Healthcare Middleware Variables, Trends & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.3.3. Industry Opportunities
- 3.4. Healthcare Middleware Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Healthcare Middleware Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Healthcare Middleware: Type Movement Analysis, 2025 & 2033 (USD Billion)
- 4.3. Communication
- 4.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4. Platform
- 4.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5. Integration
- 4.5.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.6. Others
- 4.6.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 5. Healthcare Middleware Market: Deployment Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Healthcare Middleware: Deployment Movement Analysis, 2025 & 2033 (USD Billion)
- 5.3. Cloud
- 5.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.4. On-premises
- 5.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.5. Hybrid
- 5.5.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 6. Healthcare Middleware Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Healthcare Middleware: Application Movement Analysis, 2025 & 2033 (USD Billion)
- 6.3. Clinical
- 6.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4. Financial
- 6.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.5. Operational & Administrative
- 6.5.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6. Others
- 6.6.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 7. Healthcare Middleware Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Healthcare Middleware: End Use Movement Analysis, 2025 & 2033 (USD Billion)
- 7.3. Healthcare Providers
- 7.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 7.4. Healthcare Payers
- 7.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 7.5. Pharmaceutical & Life Sciences Companies
- 7.5.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 7.6. Medical Device Companies
- 7.6.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 7.7. Clinical Laboratories
- 7.7.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 7.8. Others
- 7.8.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 8. Healthcare Middleware Market: Regional Estimates & Trend Analysis
- 8.1. Healthcare Middleware Share, By Region, 2025 & 2033 (USD Billion)
- 8.2. North America
- 8.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.2.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.2.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.2.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.2.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.2.6. U.S.
- 8.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.2.6.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.2.6.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.2.6.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.2.6.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.2.7. Canada
- 8.2.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.2.7.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.2.7.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.2.7.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.2.7.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.2.8. Mexico
- 8.2.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.2.8.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.2.8.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.2.8.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.2.8.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.3. Europe
- 8.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.3.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.3.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.3.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.3.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.3.6. UK
- 8.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.3.6.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.3.6.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.3.6.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.3.6.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.3.7. Germany
- 8.3.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.3.7.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.3.7.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.3.7.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.3.7.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.3.8. France
- 8.3.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.3.8.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.3.8.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.3.8.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.3.8.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.4.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.4.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.4.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.4.6. China
- 8.4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.6.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.4.6.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.4.6.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.4.6.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.4.7. India
- 8.4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.7.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.4.7.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.4.7.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.4.7.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.4.8. Japan
- 8.4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.8.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.4.8.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.4.8.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.4.8.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.4.9. Australia
- 8.4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.9.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.4.9.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.4.9.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.4.9.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.4.10. South Korea
- 8.4.10.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.10.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.4.10.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.4.10.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.4.10.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.5. Latin America
- 8.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.5.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.5.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.5.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.5.6. Brazil
- 8.5.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.6.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.5.6.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.5.6.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.5.6.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.6. Middle East & Africa
- 8.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.6.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.6.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.6.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.6.6. Saudi Arabia
- 8.6.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.6.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.6.6.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.6.6.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.6.6.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.6.7. UAE
- 8.6.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.7.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.6.7.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.6.7.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.6.7.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
- 8.6.8. South Africa
- 8.6.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.8.2. Market estimates and forecast by type, 2021-2033 (Revenue, USD Billion)
- 8.6.8.3. Market estimates and forecast by deployment, 2021-2033 (Revenue, USD Billion)
- 8.6.8.4. Market estimates and forecast by application, 2021-2033 (Revenue, USD Billion)
- 8.6.8.5. Market estimates and forecast by end use, 2021-2033 (Revenue, USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Market Share Analysis
- 9.4. Company Heat Map Analysis
- 9.5. Strategy Mapping
- 9.5.1. Expansion
- 9.5.2. Mergers & Acquisition
- 9.5.3. Partnerships & Collaborations
- 9.5.4. New Product Launches
- 9.5.5. Research And Development
- 9.6. Company Profiles
- 9.6.1. Cognizant
- 9.6.1.1. Participant's Overview
- 9.6.1.2. Financial Performance
- 9.6.1.3. Product Benchmarking
- 9.6.1.4. Recent Developments
- 9.6.2. Epic Systems Corporation
- 9.6.2.1. Participant's Overview
- 9.6.2.2. Financial Performance
- 9.6.2.3. Product Benchmarking
- 9.6.2.4. Recent Developments
- 9.6.3. Fujitsu Limited
- 9.6.3.1. Participant's Overview
- 9.6.3.2. Financial Performance
- 9.6.3.3. Product Benchmarking
- 9.6.3.4. Recent Developments
- 9.6.4. GE HealthCare
- 9.6.4.1. Participant's Overview
- 9.6.4.2. Financial Performance
- 9.6.4.3. Product Benchmarking
- 9.6.4.4. Recent Developments
- 9.6.5. HCLTech
- 9.6.5.1. Participant's Overview
- 9.6.5.2. Financial Performance
- 9.6.5.3. Product Benchmarking
- 9.6.5.4. Recent Developments
- 9.6.6. IBM Corporation
- 9.6.6.1. Participant's Overview
- 9.6.6.2. Financial Performance
- 9.6.6.3. Product Benchmarking
- 9.6.6.4. Recent Developments
- 9.6.7. InterSystems Corporation
- 9.6.7.1. Participant's Overview
- 9.6.7.2. Financial Performance
- 9.6.7.3. Product Benchmarking
- 9.6.7.4. Recent Developments
- 9.6.8. Koninklijke Philips N.V.
- 9.6.8.1. Participant's Overview
- 9.6.8.2. Financial Performance
- 9.6.8.3. Product Benchmarking
- 9.6.8.4. Recent Developments
- 9.6.9. Microsoft
- 9.6.9.1. Participant's Overview
- 9.6.9.2. Financial Performance
- 9.6.9.3. Product Benchmarking
- 9.6.9.4. Recent Developments
- 9.6.10. Oracle
- 9.6.10.1. Participant's Overview
- 9.6.10.2. Financial Performance
- 9.6.10.3. Product Benchmarking
- 9.6.10.4. Recent Developments
- 9.6.11. Orion Health
- 9.6.11.1. Participant's Overview
- 9.6.11.2. Financial Performance
- 9.6.11.3. Product Benchmarking
- 9.6.11.4. Recent Developments
- 9.6.12. Persistent Systems
- 9.6.12.1. Participant's Overview
- 9.6.12.2. Financial Performance
- 9.6.12.3. Product Benchmarking
- 9.6.12.4. Recent Developments
- 9.6.13. Salesforce
- 9.6.13.1. Participant's Overview
- 9.6.13.2. Financial Performance
- 9.6.13.3. Product Benchmarking
- 9.6.13.4. Recent Developments
- 9.6.14. Siemens Healthineers
- 9.6.14.1. Participant's Overview
- 9.6.14.2. Financial Performance
- 9.6.14.3. Product Benchmarking
- 9.6.14.4. Recent Developments
- 9.6.15. Tata Consultancy Services
- 9.6.15.1. Participant's Overview
- 9.6.15.2. Financial Performance
- 9.6.15.3. Product Benchmarking
- 9.6.15.4. Recent Developments
- 9.6.1. Cognizant
